TriSalus Life Sciences (TLSI) Change in Receivables (2022 - 2026)
TriSalus Life Sciences (TLSI) posted quarterly Change in Receivables of -$1.3 million for Q1 2026, down 452.73% year-over-year from $366000.0 in Q1 2025, and down 181.14% quarter-over-quarter from $1.6 million in Q4 2025.
TriSalus Life Sciences (TLSI) Change in Receivables (2022 - 2026) Analysis & Trends
TriSalus Life Sciences' Change in Receivables history runs 5 years deep, the most recent figure standing at -$1.3 million for Q1 2026.
- In Q1 2026, Change in Receivables fell 452.73% year-over-year to -$1.3 million; the TTM figure through Mar 2026 stood at -$23000.0 (down 101.69% YoY), while the FY2025 annual figure was $1.6 million, down 4.94% from the prior year.
- Change in Receivables for Q1 2026 stood at -$1.3 million, down from $1.6 million in the prior quarter.
- The five-year high for Change in Receivables was $1.6 million in Q4 2025, with the low at -$1.3 million in Q1 2026.
- The 5-year median for Change in Receivables is $363500.0 (2024), against an average of $236071.4.
- The sharpest annual moves came in 2024 and 2026: Change in Receivables jumped 1965.71% in 2024, then sank 452.73% in 2026.
- TriSalus Life Sciences' Change in Receivables stood at -$736000.0 in 2022, then soared by 168.21% to $502000.0 in 2023, then declined by 28.09% to $361000.0 in 2024, then jumped by 340.72% to $1.6 million in 2025, then tumbled by 181.14% to -$1.3 million in 2026.
- Business Quant data shows TLSI's Change in Receivables at -$1.3 million in Q1 2026, $1.6 million in Q4 2025, and -$497000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -90.00 Mn |
| 10 | TriSalus Life Sciences | 306.06 Mn | 259.77 Mn | 9.90 Mn | 1.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.27 Mn |
| Jun 30, 2026 | 1.27 Mn |
| Mar 31, 2026 | -1.29 Mn |
| Mar 31, 2026 | -1.29 Mn |
| Dec 31, 2025 | 1.59 Mn |
| Dec 31, 2025 | 1.59 Mn |
| Sep 30, 2025 | -497,000.00 |
| Sep 30, 2025 | -497,000.00 |
| Jun 30, 2025 | 174,000.00 |
| Jun 30, 2025 | 174,000.00 |
| Mar 31, 2025 | 366,000.00 |
| Mar 31, 2025 | 366,000.00 |
| Dec 31, 2024 | 361,000.00 |
| Dec 31, 2024 | 361,000.00 |
| Sep 30, 2024 | 206,000.00 |
| Sep 30, 2024 | 206,000.00 |
| Jun 30, 2024 | 429,000.00 |
| Jun 30, 2024 | 429,000.00 |
| Mar 31, 2024 | 723,000.00 |
| Mar 31, 2024 | 723,000.00 |